Page last updated: 2024-10-28

hexamethylene bisacetamide and Carcinoma, Transitional Cell

hexamethylene bisacetamide has been researched along with Carcinoma, Transitional Cell in 2 studies

N,N'-diacetyl-1,6-diaminohexane: chemical name obtained from Acta Biol Hung 1990;41(1-3):199-208

Carcinoma, Transitional Cell: A malignant neoplasm derived from TRANSITIONAL EPITHELIAL CELLS, occurring chiefly in the URINARY BLADDER; URETERS; or RENAL PELVIS.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Richon, VM1
Russo, P1
Venta-Perez, G1
Cordon-Cardo, C1
Rifkind, RA1
Marks, PA1
Xie, D1
Ren, L1
Li, LS1

Other Studies

2 other studies available for hexamethylene bisacetamide and Carcinoma, Transitional Cell

ArticleYear
Two cytodifferentiation agent-induced pathways, differentiation and apoptosis, are distinguished by the expression of human papillomavirus 16 E7 in human bladder carcinoma cells.
    Cancer research, 1997, Jul-01, Volume: 57, Issue:13

    Topics: Acetamides; Actins; Antineoplastic Agents; Apoptosis; Carcinoma, Transitional Cell; Carrier Proteins

1997
[Immobilization of N-acetyl-1,6-diaminohexane(NADAH) on diol-silica and study of mechanism of NADAH and hexamethylene bisacetamide(HMBA) inducing tumor cells differentiation].
    Se pu = Chinese journal of chromatography, 1998, Volume: 16, Issue:4

    Topics: Acetamides; Carcinoma, Transitional Cell; Cell Transformation, Neoplastic; Chromatography, High Pres

1998